QA: Tempest Therapeutics Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001544227_2019_Tempest_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0001544227', 'EntityCommonStockSharesOutstanding': 13472937, 'Assets': 74970000, 'AssetsCurrent': 71132000, 'ComprehensiveNetIncome': -44551000, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 15099000, 'LiabilitiesAndStockholdersEquity': 74970000, 'LiabilitiesCurrent': 12520000, 'LiabilitiesNoncurrent': 2579000, 'NetIncome': -44568000, 'PropertyPlantAndEquipmentNet': 0, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 3838000, 'remainder_ComprehensiveNetIncome': 17000, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_NetIncome': -44568000, 'remainder_Revenues': 0, 'remainder_StockholdersEquity': 59871000, 'obs_EconomicCapitalRatio': nan}}
info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'00200 - Statement - Consolidated statements of operations and comprehensive loss': 12, '00205 - Statement - Consolidated statements of operations and comprehensive loss (Calc 2)': 2}}

Graph

Absolute values for 0001544227, Tempest Therapeutics Inc

  xvar xval
0 AssetsCurrent 83,422,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 652,000
4 LiabilitiesCurrent 9,817,000
5 LiabilitiesNoncurrent 1,135,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 74,990
8 SellingGeneralAndAdministrativeExpense -60,729,479
9 ResearchAndDevelopmentExpense -33,093,090
10 remainder_Expenses 921,876
11 remainder_Revenues -81,735
12 remainder_NetIncome -533,578
13 remainder_ComprehensiveNetIncome 10,793
  yvar yval
0 Assets 84,074,000
1 Liabilities 10,952,000
2 Expenses -92,825,703
3 Revenues -81,735
4 StockholdersEquity 73,122,000
5 NetIncome 92,210,390
6 ComprehensiveNetIncome 92,215,786
7 BaseVar 94,238,904
8 EconomicCapitalRatiobeforeLimitedLiability 5.30
9 EconomicCapitalRatio 5.45

Edgar->Model Mapping

Feature Distribution

Change over Time